Ra Medical Systems Inc. (RMED)
AMEX: RMED
· Real-Time Price · USD
0.59
0.05 (9.26%)
At close: Aug 17, 2023, 10:00 PM
Ra Medical Systems Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 143K | 93K | 96K | 93K | 139K | 103K | 85K | 14K | n/a | 5K | 9K | 5K | 5K | 1M | 1.12M |
Cost of Revenue | 11K | 6K | 10K | 16K | 12K | 14K | 10K | 161K | n/a | 66K | 95K | 347K | 246K | 1.49M | 1.37M |
Gross Profit | 132K | 87K | 86K | 77K | 127K | 89K | 75K | -147K | n/a | -61K | -86K | -342K | -241K | -483K | -255K |
Operating Income | -3.56M | -47.91M | -2.86M | -2.72M | -2.73M | -6.29M | 45.69M | -8.21M | -4.78M | -8.46M | -5.5M | -8.26M | -7.39M | -7.24M | -7.18M |
Interest Income | 18K | -194K | 7K | 2K | 87K | 119K | 69K | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 1K |
Pretax Income | -4.77M | 56.4M | -4.12M | -4.22M | -1.93M | -1.58M | -66.4M | -8.16M | -4.76M | -8.45M | -5.5M | -8.28M | -7.38M | -5.25M | -7.24M |
Net Income | -4.04M | 48.9M | -4.12M | -4.22M | -1.93M | -1.58M | -67.2M | -8.16M | -4.74M | -8.45M | -5.5M | -8.29M | -4.3M | -5.25M | -7.24M |
Selling & General & Admin | 3.48M | 3.04M | 2.88M | 2.71M | 2.75M | 1.42M | 10.23M | 7.96M | 3.51M | 2.48M | 2.3M | 4.19M | 4.21M | 3.74M | 4.11M |
Research & Development | 103K | 214K | 63K | 81K | 112K | 134K | 240K | 154K | 727K | 2.4M | 3.12M | 3.73M | 2.94M | 3.02M | 2.82M |
Other Expenses | 108K | n/a | n/a | n/a | n/a | 4.83M | 15K | 59K | 20K | 12K | 8K | -19K | 16K | n/a | n/a |
Operating Expenses | 3.7M | 3.26M | 2.94M | 2.79M | 2.86M | 6.38M | 10.47M | 8.11M | 4.24M | 4.87M | 5.42M | 7.92M | 7.15M | 6.76M | 6.93M |
Interest Expense | -49K | -91K | -32K | n/a | n/a | n/a | n/a | 17K | n/a | n/a | n/a | n/a | n/a | 31K | 52K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.71M | 3.26M | 2.96M | 2.81M | 2.87M | 6.4M | 10.48M | 8.11M | 4.24M | 4.94M | 5.51M | 8.27M | 7.4M | 8.25M | 8.3M |
Income Tax Expense | -724K | 2.34M | n/a | n/a | n/a | n/a | 800K | 3K | -20K | n/a | n/a | 4K | -3.08M | 31K | 1K |
Shares Outstanding (Basic) | 11.28M | 3.26M | 2.05M | 7.57M | 6.81M | 5.36M | 2.73M | 2.16M | 1.09M | 643.24K | 400.75K | 134K | 128K | 81.78K | 58.34K |
Shares Outstanding (Diluted) | 11.28M | 3.26M | 2.05M | 7.57M | 6.81M | 5.36M | 2.73M | 2.16M | 1.09M | 643.24K | 400.75K | 134K | 128K | 81.78K | 58.34K |
EPS (Basic) | -0.36 | 18.54 | -2.01 | -5.57 | -0.28 | -0.29 | -24.65 | -3.78 | -4.34 | -13.13 | -13.71 | -61.84 | -33.58 | -64.18 | -124.03 |
EPS (Diluted) | -0.36 | 18.54 | -2.01 | -5.57 | -0.28 | -0.29 | -24.65 | -3.78 | -4.34 | -13.13 | -13.71 | -61.84 | -33.58 | -64.18 | -124.03 |
EBITDA | -3.56M | 49.63M | -2.86M | -2.72M | -2.73M | -6.29M | 47.13M | -7.98M | -3.63M | -1.27M | -5.32M | -8.26M | -7.03M | -6.82M | -6.73M |
EBIT | n/a | n/a | n/a | n/a | n/a | n/a | 45.69M | -8.05M | -4.78M | n/a | -5.5M | n/a | -7.39M | -5.22M | -7.18M |
Depreciation & Amortization | n/a | -1.53M | n/a | n/a | -39.59K | 122.08K | 1.44M | 231K | 1.16M | 136K | 186K | 315K | 369K | 426K | 455K |